13
Views
6
CrossRef citations to date
0
Altmetric
CASE REPORT

Pseudogout attack induced during etidronate disodium therapy

, , , , , & show all
Pages 117-119 | Received 26 Dec 2005, Accepted 22 Feb 2006, Published online: 02 Jan 2014

References

  • Gallacher SJ, Boyle IT, Capell HA. Pseudogout associated with the use of cyclical etidronate therapy. Scott Med J 1991;36(2):49.
  • Young-Min SA, Herbert L, Dick M, Fordham J. Weekly alendronate-induced acute pseudogout. Rheumatology (Oxford) 2005;44(1):131–2.
  • Malnick SD, Ariel-Ronen S, Evron E, Sthoeger ZM. Acute pseudogout as a complication of pamidronate. Ann Pharmacother 1997;31(4):499–500.
  • Japan Osteoporosis Society. Guidelines 2004. Osteoporosis Japan 2004;12:191–207.
  • Walton RJ, Russell RG, Smith R. Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man. Clin Sci Mol Med 1975;49(1):45–56.
  • Terkeltaub RA. Clinical trials review: crystal deposition diseases. Curr Rheumatol Rep 1999;1(2):97–100.
  • Shinozaki T, Pritzker KP. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions. J Rheumatol 1996; 23(4):677–83.
  • Geelhoed GW, Kelly TR. Pseudogout as a clue and complication in primary hyperparathyroidism. Surgery 1989;106(6):1036–41; discussion 41–2.
  • Gallagher JC, Riggs BL, Jerpbak CM, Arnaud CD. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med 1980;95(3):373–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.